Cerevel Therapeutics and Cyclica Announce Research Collaboration to Use Artificial Intelligence …AI & Surroundings
BOSTON & TORONTO–(BUSINESS WIRE)–Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Cyclica, whose AI-augmented, integrated platform enables multi-objective, polypharmacology-informed design of drug molecules, today announced a research collaboration aimed at accelerating the discovery of novel medicines for neuroscience diseases. Through this collaboration, Cerevel will use Cyclica’s […]
Posted from: this blog via Microsoft Flow.
Comments
Post a Comment